Establishing Mobile Transcranial Magnetic Stimulation

Conditions

• Treatment Resistant Major Depression

Eligibility Criteria

Sex

ALL

Age

22 Years - 80 Years

Healthy Volunteers

Not accepted

Interventions

• Left prefrontal Transcranial Magnetic Stimulation (TMS) — DEVICE
  FDA cleared TMS
• FDA cleared TMS for treating depression — DEVICE
  This is FDA approved TMS

Study Details

In this pilot study, investigators propose to design and create a portable TMS unit, in a van, and then test out delivering TMS in three different locations in South Carolina, all affiliated with MUSC and within 2-hours driving from Charleston, SC. This study would test out this new delivery mode, and provide valuable feasibility, safety, and efficacy lessons for later refinement and potential widespread adoption of mobile TMS as a treatment option, both in our state and across the US.

Key Dates

Start date

May 10, 2025

Status verified

May 2026

Primary completion

Mar 1, 2027

Completion

Mar 1, 2028

Study Design

Enrollment

30 participants (estimated)

Allocation

NA

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Arms

• Other: Open label Clinical TMS for Depression
  This will be FDA approved Left Prefrontal TMS for treating depression, we will be performing this within a VA, located at clinics throughout SC.

Primary Outcome Measure

Percent of depression responders [ Time Frame: From baseline to 1 week immediately after treatment week ]

Central Contacts

• Mark S George, MD
  8438765142
  [email protected]
• Alexandra Herron, BA
  [email protected]

Locations (1)

Find similar trials in Charleston, SC